- Home
- NTZ vs KZR Comparison
NTZ vs KZR Comparison
Compare NTZ & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTZ
- KZR
- Stock Information
- Founded
- NTZ 1959
- KZR 2015
- Country
- NTZ Italy
- KZR United States
- Employees
- NTZ N/A
- KZR N/A
- Industry
- NTZ Home Furnishings
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- NTZ Consumer Discretionary
- KZR Health Care
- Exchange
- NTZ Nasdaq
- KZR Nasdaq
- Market Cap
- NTZ 52.3M
- KZR 43.0M
- IPO Year
- NTZ 1993
- KZR 2018
- Fundamental
- Price
- NTZ $4.90
- KZR $6.05
- Analyst Decision
- NTZ
- KZR Hold
- Analyst Count
- NTZ 0
- KZR 2
- Target Price
- NTZ N/A
- KZR $9.00
- AVG Volume (30 Days)
- NTZ 7.1K
- KZR 26.2K
- Earning Date
- NTZ 04-04-2025
- KZR 03-13-2025
- Dividend Yield
- NTZ N/A
- KZR N/A
- EPS Growth
- NTZ N/A
- KZR N/A
- EPS
- NTZ N/A
- KZR N/A
- Revenue
- NTZ $365,846,531.00
- KZR N/A
- Revenue This Year
- NTZ N/A
- KZR N/A
- Revenue Next Year
- NTZ N/A
- KZR N/A
- P/E Ratio
- NTZ N/A
- KZR N/A
- Revenue Growth
- NTZ N/A
- KZR N/A
- 52 Week Low
- NTZ $3.80
- KZR $5.20
- 52 Week High
- NTZ $6.49
- KZR $11.40
- Technical
- Relative Strength Index (RSI)
- NTZ 52.96
- KZR 43.79
- Support Level
- NTZ $4.70
- KZR $5.86
- Resistance Level
- NTZ $5.42
- KZR $6.57
- Average True Range (ATR)
- NTZ 0.20
- KZR 0.27
- MACD
- NTZ -0.02
- KZR 0.02
- Stochastic Oscillator
- NTZ 27.78
- KZR 25.97
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio including sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of revenue from the United States of America and also has an international presence in Italy, Spain, UK and Other countries.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.